Vectors Research Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Vectors Research Management, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$902.69 - $993.35 $35,204 - $38,740	-39 Reduced 3.67%	1,025 $987,000
Q4 2023 Feb 12, 2024	SELL	$775.18 - $881.7 $9,302 - $10,580	-12 Reduced 1.12%	1,064 $935,000
Q3 2023 Nov 09, 2023	SELL	$692.45 - $844.37 $9,001 - $10,976	-13 Reduced 1.19%	1,076 $849,000
Q2 2023 Aug 08, 2023	SELL	$700.03 - $830.35 $51,102 - $60,615	-73 Reduced 6.28%	1,089 $782,000
Q1 2023 May 04, 2023	SELL	$680.49 - $826.97 $5,443 - $6,615	-8 Reduced 0.68%	1,162 $955,000
Q4 2022 Feb 08, 2023	SELL	$705.89 - $766.39 $28,941 - $31,421	-41 Reduced 3.39%	1,170 $844,000
Q3 2022 Nov 08, 2022	SELL	$573.97 - $724.32 $10,331 - $13,037	-18 Reduced 1.46%	1,211 $834,000
Q2 2022 Aug 12, 2022	SELL	$548.35 - $738.84 $20,837 - $28,075	-38 Reduced 3.0%	1,229 $726,000
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $11,902 - $13,968	-20 Reduced 1.55%	1,267 $885,000
Q4 2021 Feb 15, 2022	BUY	$543.48 - $670.97 $21,195 - $26,167	39 Added 3.13%	1,287 $813,000
Q3 2021 Nov 12, 2021	BUY	$574.03 - $680.96 $20,665 - $24,514	36 Added 2.97%	1,248 $755,000
Q2 2021 Aug 09, 2021	BUY	$472.8 - $558.54 $17,493 - $20,665	37 Added 3.15%	1,212 $676,000
Q1 2021 May 18, 2021	BUY	$446.73 - $548.2 $524,907 - $644,135	1,175 New	1,175 $556,000
Q3 2020 Nov 16, 2020	SELL	$544.75 - $658.21 $13,618 - $16,455	-25 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$274.13 - $376.51 $6,853 - $9,412	25 New	25 $9,000

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Vectors Research Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Vectors Research Management, LLC with notifications on news.